Sphingosine-1-phosphate - sphinganine-1-phosphate Imbalance Drives Airway Hyperreactivity

Area of Science:

• Biochemistry
• Genetics
• Pulmonology

Background:

• Asthma is a common childhood respiratory disease.
• Genetic variants at the 17q21 locus are linked to asthma risk.
• These variants affect ORMDL3, regulating sphingolipid synthesis.

Purpose of the Study:

• To investigate the role of sphingolipid metabolites in airway smooth muscle reactivity.
• To understand the mechanisms connecting altered sphingolipid metabolism to asthma-related airway dysfunction.

Main Methods:

• Quantified circulating sphingolipids in children with asthma and risk alleles.
• Assessed airway responses in precision-cut lung slices from mice with reduced serine palmitoyl-CoA transferase (SPT) activity.
• Exposed lung slices to sphingosine-1-phosphate (S1P), sphinganine-1-phosphate (Sa1P), and S1P receptor antagonists.

Main Results:

• Homozygous carriers of the 17q21 risk allele and SPT-deficient mice showed an elevated S1P/Sa1P ratio.
• Sa1P demonstrated an opposing effect to S1P-induced airway contraction.
• Increased Sa1P availability led to reduced airway hyperresponsiveness.

Conclusions:

• The S1P/Sa1P axis acts as a metabolic regulator of airway smooth muscle tone.
• Targeting sphingolipid metabolism presents a potential therapeutic strategy for asthma.
• This study reveals a link between the 17q21 locus, sphingolipid imbalance, and airway hyperreactivity.